15965-58-9 Usage
Uses
Used in Organic Synthesis:
1H-Benzimidazole,2-chloro-4-methoxy-(9CI) is used as a synthetic intermediate for the preparation of a range of organic compounds. Its unique structure allows for the development of new chemical entities with potential applications across different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1H-Benzimidazole,2-chloro-4-methoxy-(9CI) is used as a building block for the synthesis of bioactive molecules. Its potential role in the development of new drugs makes it a valuable asset in medicinal chemistry, particularly for the treatment of various diseases and medical conditions.
Used in Drug Development:
1H-Benzimidazole,2-chloro-4-methoxy-(9CI) is employed in the research and development of new pharmaceuticals. Its biological activity and pharmacological properties are of interest for further study, with the aim of discovering its full potential in treating specific health issues. However, additional research and testing are necessary to fully comprehend its capabilities and effects.
While the provided materials do not specify particular applications or industries for 1H-Benzimidazole,2-chloro-4-methoxy-(9CI), the general uses outlined above reflect its role in organic synthesis and pharmaceutical research, as well as its potential in drug development. Further exploration and studies are required to determine its specific applications and therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 15965-58-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,6 and 5 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 15965-58:
(7*1)+(6*5)+(5*9)+(4*6)+(3*5)+(2*5)+(1*8)=139
139 % 10 = 9
So 15965-58-9 is a valid CAS Registry Number.
15965-58-9Relevant academic research and scientific papers
Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4′-piperidin]-1′-yl}benzimidazole derivatives
Ogino, Yoshio,Ohtake, Norikazu,Nagae, Yoshikazu,Matsuda, Kenji,Moriya, Minoru,Suga, Takuya,Ishikawa, Makoto,Kanesaka, Maki,Mitobe, Yuko,Ito, Junko,Kanno, Tetsuya,Ishihara, Akane,Iwaasa, Hisashi,Ohe, Tomoyuki,Kanatani, Akio,Fukami, Takehiro
scheme or table, p. 5010 - 5014 (2009/05/07)
Design, syntheses, and structure-activity relationships of a novel class of 2-{3-oxospiro[isobenzofuran-1(3H),4′-piperidin]-1′-yl}benzimidazole NPY Y5 receptor antagonists are described. The benzimidazole structures were newly designed based on the urea linkage of our prototype Y5 receptor antagonists (2 and 3). By optimizing substituents on the benzimidazole core part of the lead compound 5a, we were able to develop a potent, orally available, and brain-penetrable Y5 selective antagonist (5k). Crown Copyright
